Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.
PHASE2
The purposes of this study are to determine:
1. The safety of pemetrexed p...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML)
PHASE1
This open-label Phase I study is designed to determine the maximum tolerate...
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases
PHASE1
The goal of this study is to evaluate the safety and efficacy of CD19 CAR T...
Status
Not Yet Recruiting
Location
Henan Province Engineering Technology Research Center of Immunological Precision Medicine and Artificial Intelligence Application, The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang, China